Arm access showdown: which method is safer for artery procedures?

NCT ID NCT07573644

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two methods of accessing the brachial artery in the arm for treating blocked leg arteries: a needle poke through the skin (percutaneous) versus a small cut (open). About 246 adults will be randomly assigned to one method. The goal is to see which approach causes fewer complications at the access site.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this trial succeeds, it could help doctors choose the safer method for accessing the brachial artery during endovascular procedures, potentially reducing complications.
What could go wrong
This is an early-stage comparative study with no direct treatment benefit. Results may not apply to all patients or settings, and complication rates could vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOVASCULAR SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH de Cholet

    Cholet, 49309, France

  • CH de Saint Brieuc

    Saint-Brieuc, 22000, France

  • CHD La Roche-sur- Yon

    La Roche-sur-Yon, 85000, France

  • CHU Bordeaux

    Bordeaux, 33000, France

  • CHU Brest

    Brest, 29200, France

  • CHU Nantes

    Nantes, 44008, France

  • CHU d'Angers

    Angers, 49100, France

  • CHU de Rennes

    Rennes, 35000, France

  • Clinique mutualiste porte de Lorient

    Lorient, 56100, France

  • Hôpital Paris Saint Joseph

    Paris, 75014, France

  • Hôpital privé des Côtes d'Armor

    Plérin, 22190, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.